Home > Result Summaries: Compounds > ropinirole > Result Summary for 101468/243

Result Summary for 101468/243

Result Summary

Protocol ID:	101468/243
Clinical Study ID:	101468/243
Official Title:	A 52 Week Open-Label Extension Study of the Long-Term Safety of Ropinirole in Subjects Suffering from Restless Legs Syndrome (RLS)
Phase:	Phase 3
Study Indications or Diseases:	Restless Legs Syndrome
Generic Name:	ropinirole
Trade/Product Name:	Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Dreykluft T, Karrasch J, Smuts J, Volc D, Grunstein R, Montplaisir J. The long-term safety and tolerability of ropinirole in RLS. International Congress of Parkinson’s Disease and Movement Disorders, Rome, Italy, Jun 13–17 2004. Mov Disord 2004; 19(suppl 9): S430: P1262